Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The drug-eluting stent information gap.

Cynthia A Yock1, Paul G Yock

  • 1Center for Primary Care and Outcomes Research, Stanford University School of Medicine, 117 Encina Commons, Stanford, CA 94305-6019, USA. yock@healthpolicy.stanford.edu

The American Heart Hospital Journal
|December 18, 2004
PubMed
Summary

Drug-eluting stents are now common, but data from FDA approval trials may not fully represent real-world patient outcomes. More research is needed for a comprehensive understanding of their population-level performance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of myocardial bridging on coronary artery plaque formation and long-term mortality after heart transplantation.

International journal of cardiology·2023
Same author

Impact of Diastolic Vessel Restriction on Quality of Life in Symptomatic Myocardial Bridging Patients Treated With Surgical Unroofing: Preoperative Assessments With Intravascular Ultrasound and Coronary Computed Tomography Angiography.

Circulation. Cardiovascular interventions·2021
Same author

Head-to-head comparison of quantitative measurements between intravascular imaging systems: An in vitro phantom study.

International journal of cardiology. Heart & vasculature·2021
Same author

Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials.

Journal of cardiology·2021
Same author

Deep learning-based intravascular ultrasound segmentation for the assessment of coronary artery disease.

International journal of cardiology·2021
Same author

Scaffold underexpansion and late lumen loss after bioresorbable scaffold implantation: Insights from ABSORB JAPAN trial.

International journal of cardiology. Heart & vasculature·2020

Area of Science:

  • Cardiovascular Medicine
  • Medical Devices
  • Interventional Cardiology

Background:

  • Drug-eluting stents (DES) are increasingly preferred over bare-metal stents for arterial revascularization.
  • Current understanding of DES patient outcomes primarily stems from trials supporting US Food and Drug Administration (FDA) approval.

Purpose of the Study:

  • To highlight the limitations of FDA trial data for assessing real-world DES performance.
  • To emphasize the need for broader data to understand population-level outcomes with DES.

Main Methods:

  • Analysis of existing literature and clinical trial data for drug-eluting stents.
  • Comparison of data from FDA approval trials versus real-world evidence.

Main Results:

Related Experiment Videos

  • Existing data predominantly reflects outcomes from controlled FDA trials.
  • A gap exists in comprehensive, population-level data on DES performance in diverse patient groups.

Conclusions:

  • Current evidence may not fully capture the long-term, real-world effectiveness and safety of DES.
  • Further research incorporating real-world data is crucial for a complete understanding of DES in clinical practice.